Clorox (CLX) Given a $131.00 Price Target by Barclays Analysts

Clorox (NYSE:CLX) received a $131.00 price objective from equities research analysts at Barclays in a research report issued to clients and investors on Saturday. The brokerage currently has a “hold” rating on the stock. Barclays’ price objective would suggest a potential downside of 12.42% from the company’s previous close.

Several other brokerages also recently weighed in on CLX. ValuEngine raised Clorox from a “hold” rating to a “buy” rating in a report on Saturday, September 22nd. Atlantic Securities began coverage on Clorox in a report on Thursday, September 20th. They set a “neutral” rating and a $151.00 price target for the company. Argus raised Clorox from a “hold” rating to a “buy” rating and set a $175.00 price target for the company in a report on Tuesday, September 25th. Zacks Investment Research downgraded Clorox from a “buy” rating to a “hold” rating in a report on Friday. Finally, BMO Capital Markets reaffirmed a “buy” rating and set a $153.00 price target on shares of Clorox in a report on Friday, August 3rd. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $137.00.

Shares of NYSE CLX opened at $149.58 on Friday. The company has a debt-to-equity ratio of 3.15, a current ratio of 1.09 and a quick ratio of 0.67. Clorox has a 1-year low of $113.57 and a 1-year high of $153.38. The firm has a market cap of $19.21 billion, a P/E ratio of 23.89, a P/E/G ratio of 3.11 and a beta of 0.36.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, August 2nd. The company reported $1.66 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.58 by $0.08. Clorox had a return on equity of 103.18% and a net margin of 13.44%. The firm had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.72 billion. During the same period last year, the company earned $1.53 earnings per share. The company’s revenue for the quarter was up 2.7% on a year-over-year basis. On average, sell-side analysts predict that Clorox will post 6.41 earnings per share for the current fiscal year.

In other Clorox news, EVP Linda J. Rendle sold 382 shares of the firm’s stock in a transaction on Thursday, September 6th. The stock was sold at an average price of $148.32, for a total value of $56,658.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Dawn C. Willoughby sold 3,387 shares of Clorox stock in a transaction on Wednesday, September 5th. The stock was sold at an average price of $148.01, for a total value of $501,309.87. The disclosure for this sale can be found here. In the last three months, insiders sold 29,268 shares of company stock valued at $4,196,686. 1.00% of the stock is owned by corporate insiders.

Large investors have recently added to or reduced their stakes in the company. Cornerstone Wealth Management LLC acquired a new position in shares of Clorox during the 2nd quarter worth $105,000. Ostrum Asset Management acquired a new position in shares of Clorox during the 1st quarter worth $112,000. Fort L.P. acquired a new position in shares of Clorox during the 2nd quarter worth $129,000. Whittier Trust Co. of Nevada Inc. raised its stake in shares of Clorox by 1,297.4% during the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,621 shares of the company’s stock worth $148,000 after buying an additional 1,505 shares during the last quarter. Finally, IMS Capital Management acquired a new position in shares of Clorox during the 2nd quarter worth $161,000. 78.36% of the stock is owned by institutional investors and hedge funds.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Further Reading: How can investors find ex-dividend dates?

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply